Anti-IL-17 Antibody Improves Hepatic Steatosis by Suppressing Interleukin-17-Related Fatty Acid Synthesis and Metabolism
To investigate the relationship between interleukin-17 and proteins involved in fatty acid metabolism with respect to alcoholic liver disease, male ICR mice were randomized into five groups: control, alcoholic liver disease (ALD) at 4 weeks, 8 weeks, and 12 weeks, and anti-IL-17 antibody treated ALD...
Saved in:
| Main Authors: | Weidong Shi, Qiang Zhu, Jian Gu, Xiaoshan Liu, Ling Lu, Xiaofeng Qian, Jian Shen, Feng Zhang, Guoqiang Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Clinical and Developmental Immunology |
| Online Access: | http://dx.doi.org/10.1155/2013/253046 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The role of interleukin 17 in the pathogenesis of rheumatoid arthritis. Are there any prospects for the use of IL-17 inhibitors?
by: E. L. Nasonov, et al.
Published: (2023-04-01) -
Interleukin-17: A Promoter in Colorectal Cancer Progression
by: Dang Wu, et al.
Published: (2013-01-01) -
The role of interleukin-17 in neurological disorders
by: Seung Eun Park, et al.
Published: (2025-12-01) -
The Role of Interleukin-17 in Lung Cancer
by: Feng Wu, et al.
Published: (2016-01-01) -
Cytokine dynamics in vitiligo: the roles of interleukin-10 and interleukin-17
by: Hanan Mohammed Saied
Published: (2025-08-01)